MIRM insiders

14 insiders have filed at MIRM since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.

namerolereported stake% of companybuys (3y)sells (3y)
Heron Patrick JDirector4.03M6.851%18 buys $13.6M
Peetz ChristopherChief Executive Officer381.8k0.649%16 sells $15.4M
Grey Michael GDirector280.2k0.476%5 sells $11.6M
Longpre LaraChief Development Officer104.4k0.177%1 buys $10k4 sells $97k
Vig PamelaChief Scientific Officer102.4k0.174%5 sells $1.2M
Bjerkholt EricChief Financial Officer49.8k0.085%3 buys $398k4 sells $1.6M
Radovich PeterPresident And COO40.3k0.068%15 sells $4.0M
Quan JoanneChief Medical Officer18.9k0.032%4 sells $1.8M
Brege LauraDirector15.7k0.027%2 sells $1.3M
Howe JolandaSVP, Global Controller8.4k0.014%22 sells $4.5M
Cardon LonDirector5.7k0.01%
Walbert Timothy PDirector5.7k0.01%
Fairey WilliamDirector2.5k<0.01%1 sells $155k
Ramasastry SairaDirector9 sells $1.6M

Full register at boothcheck.com/insiders/MIRM. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.

MIRM institutional holders · MIRM research report